Our Small-Cap Name Is Tanking and Nobody Knows Why
Ocular Therapeutix is selling off sharply, taking our small-cap portfolio down with it.
New Nvidia Price Target After $150 Billion Record Stock Buy
The elite-level AI chip firm announced a move that pushed Apple’s $110 billion buy into second place.
I Usually Trade Risky Small Caps. Here’s Why I’m Also in Amazon, SpaceX
Let me explain how I’m playing SPCX and how it fits into my trading style.
These 3 Stocks Have Nothing in Common … Except Their Chart Trends
An apparel play, adhesives company and a biotech are all moving in the same direction: down.
How to Join Michael Burry’s Birkenstock Bet
Here’s a covered-call strategy to join the “Big Short” investor’s fashion bet.
Amazon Faces 1 Big Obstacle Before Becoming a Buy
Amazon sports three wide moat businesses and almost universally positive analyst coverage. So why isn’t it a buy?
Thinking of Buying Costco? Here’s Why I’d Keep It on a Short Leash
Let’s take a close look at this big-box retailer after it posted a solid earnings beat.
Three Biotechs Bolstered by Positive News
Biotech has been a market laggard lately, but I’m eyeing three companies making recent progress.
Selling Some Planet Labs After Major Google Announcement
The news likely helped push the major space stocks higher.